MK-8266

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MK-8266, covering 2018-11-05 to 2019-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008) [Phase 1]

See pricing